Recruiting

Prostate Stimulation

Sponsor:

Stanford University

Code:

NCT05468931

Conditions

Sexual Dysfunction

Erectile Dysfunction

Delayed Ejaculation

Anorgasmia

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Prostate stimulator

Study Details

Brief summary:

The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.

Conditions

Sexual Dysfunction

Erectile Dysfunction

Delayed Ejaculation

Anorgasmia

Study ID

NCT05468931

Start date

Apr 18, 2024

Status verified date

May, 2025

Completion date

Jun 1, 2026

Anticipated

Primary completion date

Jun 1, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Males >18 years of age suffering from sexual dysfunction

Exclusion Criteria:

  • Individuals who have had a prostatectomy - removal of prostate
  • Inability to operate the device for any reason
  • Females
  • Males <18 years of age

Study Design

Enrollment

15 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Arms

experimental: Prostate stimulation device arm

Participants will be asked to use our prostate stimulation device.

Interventions

Prostate stimulator

Prostate stimulation device for sexual dysfunction

Primary outcome measure

  • change in modified International Index of Erectile Dysfunction score [ Time Frame: baseline and up to 1 month post-baseline ]

Central Contacts and Locations

Central contacts

Satvir Basran

650-723-0948sbasran@stanford.edu

Locations

Stanford Healthcare, Stanford Hospital

Recruiting

Stanford, California, United States, 94304

Contacts

Satvir Basran

650-723-0948sbasran@stanford.edu

More Information

Sponsor

Stanford University

Last update posted

Jun 3, 2025

Last verified

May, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Stanford University on 2025-06-03.